Seizert Capital Partners LLC Invests $340,000 in CynergisTek Inc (NYSEAMERICAN:CTEK)

Seizert Capital Partners LLC bought a new position in CynergisTek Inc (NYSEAMERICAN:CTEK) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 70,147 shares of the company’s stock, valued at approximately $340,000. Seizert Capital Partners LLC owned about 0.72% of CynergisTek at the end of the most recent quarter.

Separately, Globeflex Capital L P lifted its holdings in shares of CynergisTek by 18.5% during the first quarter. Globeflex Capital L P now owns 83,282 shares of the company’s stock valued at $414,000 after purchasing an additional 12,982 shares in the last quarter.

In other news, Director Judith Finger Krandel bought 10,000 shares of the stock in a transaction on Thursday, August 22nd. The shares were bought at an average price of $3.32 per share, with a total value of $33,200.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Paul Thomas Anthony bought 10,800 shares of the stock in a transaction on Friday, August 16th. The stock was purchased at an average cost of $3.10 per share, for a total transaction of $33,480.00. The disclosure for this purchase can be found here. In the last three months, insiders acquired 30,800 shares of company stock worth $99,180.

Shares of NYSEAMERICAN:CTEK traded down $0.11 during midday trading on Friday, reaching $3.23. 36,732 shares of the company’s stock traded hands, compared to its average volume of 26,942. CynergisTek Inc has a one year low of $2.78 and a one year high of $5.00.

CynergisTek (NYSEAMERICAN:CTEK) last posted its earnings results on Tuesday, August 13th. The company reported ($0.05) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.02. The firm had revenue of $5.06 million during the quarter, compared to the consensus estimate of $5.80 million.

A number of research analysts have recently issued reports on CTEK shares. Zacks Investment Research raised CynergisTek from a “sell” rating to a “hold” rating in a report on Tuesday, June 4th. B. Riley set a $7.00 price target on CynergisTek and gave the company a “buy” rating in a report on Friday, August 16th.

CynergisTek Company Profile

Cynergistek, Inc provides outsourced document solutions, IT consulting data security, and managed print services primarily to the healthcare industry in the United States. The company offers Incident Response, Vendor Security Management, and Patient Privacy Monitoring Service, as well as Compliance Assist Partner Program.

Recommended Story: How do analysts define an oversold condition?

Institutional Ownership by Quarter for CynergisTek (NYSEAMERICAN:CTEK)

Receive News & Ratings for CynergisTek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CynergisTek and related companies with's FREE daily email newsletter.